ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
January 21, 2019JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald. -
JW Pharmaceutical gains Korean approval for Hemlibra firstwordpharma
January 21, 2019JW Pharmaceutical said Sunday that it gained the South Korean drug regulator's approval to begin domestic sales of the hemophilia treatment Hemlibra, developed by Roche's Chugai unit, reported The Korea Herald. -
JW Pharmaceutical invests in British anti-cancer drugs developer
pharmaceutical-technology
October 30, 2018South Korea-based pharmaceutical products company JW Pharmaceutical has invested $2.6m in British anti-cancer drugs developer Argonaut Therapeutics.
Pharma Sources Insight January 2025
